GoodRx unit amends, extends revolving credit facility to 2025

By Mary-Katherine Stinson

Lexington, Ky., Feb. 26 – GoodRx Inc., an indirect wholly owned subsidiary of GoodRx Holdings, Inc., amended its first-lien credit agreement on Feb. 20, according to an 8-K filing with the Securities and Exchange Commission.

The fifth amendment extends the maturity date of its $100 million revolving credit facility to July 11, 2025 from Oct. 11, 2024.

GoodRx paid an extension fee equal to 0.125% of the revolving commitments of each extending revolving lender.

All other material provisions of the credit agreement, including the terms of the company’s term loan facility, were unchanged.

Barclays is the administrative agent.

As previously reported, GoodRx recently pulled a $662 million seven-year term loan B (B1) from the primary market.

GoodRx is a Santa Monica, Calif.-based consumer-focused digital health care platform.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.